Background The past two decades have witnessed an epidemic of opioid use disorder
(OUD) in the USA, resulting in catastrophic loss of life secondary to opioid overdoses …

Aims Smoking prevalence is higher among people enrolled in addiction treatment compared
with the general population, and very high rates of smoking are associated with opiate drug …

Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the
opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine …

Objective. To identify factors associated with opioid use during pregnancy and to compare
perinatal morbidity, mortality, and healthcare costs between opioid users and nonusers …

Opioid-related overdose deaths have reached epidemic levels within the last decade. The
efforts to prevent, identify, and treat opioid use disorders (OUDs) mostly focus on the …

Aims This paper reviews the published literature regarding outcomes following maternal
treatment with buprenorphine in five areas: maternal efficacy, fetal effects, neonatal effects …

Objective There is no consensus on the optimal perioperative management of patients on
buprenorphine (BUP) for opioid use disorder (OUD). This article will review the available …

Opioid use disorder (OUD), a leading cause of morbidity and mortality in the USA, can be
effectively treated with buprenorphine. However, the same pharmacologic properties (eg …

Until recently, the belief that adequate pain management was not achievable while patients
remained on buprenorphine was the impetus for the perioperative discontinuation of …

Background An increasing number of patients with opioid use disorder (OUD) are treated
with opioid agonist-antagonists such as buprenorphine/naloxone. Perioperative …